Sponsor:
Innova Vascular, Inc.
Code:
NCT06041594
Conditions
Pulmonary Embolism
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Laguna Thrombectomy System
Brief summary:
Conditions
Pulmonary Embolism
Study ID
NCT06041594
Start date
Aug 19, 2024
Status verified date
Jul, 2026
Completion date
Sep, 2026
Anticipated
Primary completion date
Aug, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
107 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Laguna Thrombectomy System
Interventions
Laguna Thrombectomy System
Primary outcome measure
Central contacts
Locations
Grandview Medical Center
Recruiting
Birmingham, Alabama, United States, 35243
University of Arizona
Recruiting
Tucson, Arizona, United States, 85724
University of California Irvine
Recruiting
Irvine, California, United States, 92697
Memorial Care Long Beach Medical Center
Recruiting
Long Beach, California, United States, 90806
Mission Hospital Regional Medical Center
Recruiting
Mission Viejo, California, United States, 92691
St. Joseph Hospital of Orange
Recruiting
Orange, California, United States, 92868
George Washington University
Recruiting
Washington D.C., District of Columbia, United States, 20037
Manatee Memorial Hospital
Recruiting
Bradenton, Florida, United States, 34209
Physicians Regional Medical Center
Recruiting
Naples, Florida, United States, 34119
University of North Carolina at Chapel Hill
Recruiting
Chapel Hill, North Carolina, United States, 27599
OhioHealth Research Institute
Recruiting
Columbus, Ohio, United States, 43214
Turkey Creek Medical Center
Recruiting
Knoxville, Tennessee, United States, 37934
University of Texas Southwestern
Recruiting
Dallas, Texas, United States, 75390
Sponsor
Innova Vascular, Inc.
Last update posted
Jul 17, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Innova Vascular, Inc. on 2026-07-17.